Press Releases

05.18.2016

Merck KGaA, Darmstadt, Germany, and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting

05.18.2016

Pfizer to Showcase Diverse and Growing Oncology Portfolio at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting

05.17.2016

Global Survey Finds Disconnects Between Physicians and People Living With Rheumatoid Arthritis (RA)

05.16.2016

Pfizer to Acquire Anacor

05.13.2016

Pfizer Presents Results from Two Phase 3 TRUMENBA® (Meningococcal Group B Vaccine) Studies at the European Society for Paediatric Infectious Diseases Meeting

05.11.2016

Pfizer Awards More Than $1 Million in Metastatic Breast Cancer Research Funding Through Breast Cancer: A Story Half Told Initiative

05.10.2016

AM‐Pharma publishes safety and pharmacokinetic data from Phase I recAP trial

05.10.2016

First Dosing of Pfizer DART Candidate in Phase 1 Study Triggers Milestone Payment to MacroGenics

05.05.2016

WAVE Life Sciences Enters Collaboration with Pfizer to Develop Genetically Targeted Therapies for the Treatment of Metabolic Diseases

05.03.2016

PFIZER REPORTS FIRST-QUARTER 2016 RESULTS

04.28.2016

Pfizer Hosts Annual Meeting of Shareholders

04.26.2016

AM‐Pharma receives FDA fast track designation for recAP in Acute Kidney Injury, and reports completion of first stage in Phase II trial